Third Generation Sequencing Market, By Type of Technology, By Component, By Application, By End-User, By Geography

Description

Third Generation Sequencing Market is estimated to be valued at USD 1069.1 Mn in 2026 and is expected to reach USD 4,131.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 21.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1069.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	21.30%	2033 Value Projection:	USD 4,131 Mn

Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the 'gold-standard' technology for cDNA sequencing.

Market Dynamics

Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.

For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. TGS technologies can be utilized in studying gene expression of chronic diseases as it help in understanding their molecular mechanisms. According to the World Health Organization (WHO), September 2023 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include PacBio , Oxford Nanopore Technologies, Ltd., BGI Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC Biotech AG, and Phase Genomics, Inc., among others
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.

Market Segmentation

By Technology (Revenue, USD Mn, 2021 - 2033)
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Synthetic long-read sequencing
By Component (Revenue, USD Mn, 2021 - 2033)
Products
Services
By (Revenue, USD Mn, 2021 - 2033) Application
Genome Sequencing
Epigenetics
Transcriptomics
Metagenomics
Others
By End-user (Revenue, USD Mn, 2021 - 2033)
Biopharmaceutical companies
Hospitals and clinics
Contract research organizations (CROs)
Others (Academic and research institutes)
By Geography (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
PacBio
Oxford Nanopore Technologies, Ltd.
BGI Genomics Co., Ltd.
F.Hoffmann-La Roche AG
Illumina, Inc.
Thermo Fisher Scientific Inc.
QIAGEN N.V.
Agilent Technologies, Inc.
GenapSys Inc.
Loop Genomics
Nabsys, Inc.
Genia Technologies, Inc.
Stratos Genomics, Inc.
GATC Biotech AG
Phase Genomics, Inc.

Product Code: CMI5721

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Third Generation Sequencing, By Type of Technology
- Market Third Generation Sequencing, By Component
- Market Third Generation Sequencing, By Application
- Market Third Generation Sequencing, By End User
- Market Third Generation Sequencing, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing Demand for Precision Medicine
- High Cost & Technical Challenges
- Increasing Adoption of TGS Platforms
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Third Generation Sequencing Market, By Technology, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Single-molecule real-time (SMRT) sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Nanopore Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Synthetic long-read sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

5. Third Generation Sequencing Market, By Component, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
  - Instruments
  - Reagents and consumables
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

6. Third Generation Sequencing Market, By Application, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Genome Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Epigenetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Transcriptomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Metagenomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

7. Third Generation Sequencing Market, By End User, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Contract research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

8. Third Generation Sequencing Market, By Geography, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

PacBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Nanopore Technologies, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenapSys Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Loop Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nabsys, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genia Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stratos Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GATC Biotech AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Phase Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us